LEVELS – A Whole New Level

#283 - Brain health explained: Insulin resistance, biomarkers, and Alzheimer’s risk | Dr. David Perlmutter & Mike Haney

Oct 9, 2025
Dr. David Perlmutter, a board-certified neurologist and bestselling author, joins Mike Haney to discuss the surprising connections between brain health and metabolic factors. They explore why Alzheimer's is referred to as 'Type 3 diabetes' and how insulin resistance affects cognitive decline. Perlmutter shares insights on key biomarkers that can predict dementia risk decades early and emphasizes the importance of lifestyle choices over pharmaceuticals. The conversation also delves into the potential of GLP-1 medications and practical steps for protecting brain health.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Alzheimer’s Is A Metabolic Problem

  • Alzheimer's is not just age or genes; metabolic health, especially insulin resistance, plays a central role.
  • Addressing metabolism upstream offers major prevention opportunities decades before symptoms.
ADVICE

Prefer Metabolism-Improving Drugs

  • If choosing diabetes medication, prefer ones that improve metabolism and reduce inflammation like GLP-1 agonists.
  • Use metabolic drugs selectively and remember they signal metabolism is the core target, not a magic cure.
INSIGHT

Insulin Shapes Brain Immunometabolism

  • Insulin acts as a trophic hormone in the brain, supporting neuron growth, synapses, and blood-brain-barrier integrity.
  • Insulin resistance shifts microglia to a damaging phenotype, linking systemic metabolism to neurodegeneration.
Get the Snipd Podcast app to discover more snips from this episode
Get the app